Court denies ViroPharma's motion to block generic Vancocin
This article was originally published in Scrip
Executive Summary
A US district judge on 23 April denied ViroPharma's motion for an injunction and a restraining order to try to block generic versions of the firm's Vancocin (vancomycin hydrochloride) from entering the US market.